SCHEMBL5936780

SCHEMBL5936780

C=C(C(CCC)C(=O)O)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.43
AKR1A1 P14550 1/20 0.43
CHRM3 P20309 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
ADRA1A P35348 1/20 0.43
HRH1 P35367 1/20 0.43
DRD3 P35462 1/20 0.43
SLC6A3 Q01959 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAPT P10636 1/20 0.35
GRIK1 P39086 1/20 0.34
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
GRIK2 Q13002 1/20 0.34
FAAH O00519 7/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5936782 0.88 CA2 (0.44) MAPTSLC1A3SLC1A2SLC1A1FAAH
SCHEMBL5936765 0.82 NFKB1 (0.45) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL499963 0.78 CHRM1 (0.46) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL27448050 0.75 CHRM1 (0.52) CHRM1AKR1A1CHRM3HTR2AHTR2C
Ethylene SCHEMBL27815506 0.74 CHRM1 (0.57) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL31607 0.74 HDAC1 (0.63) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL8131755 0.73 CHRM1 (0.50) CHRM1AKR1A1CHRM3HTR2AHTR2C
Hydrochloric Acid SCHEMBL628201 0.71 CHRM1 (0.60) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL21295009 0.71 CHRM1 (0.60) CHRM1AKR1A1CHRM3HTR2AHTR2C
Calcium SCHEMBL6995406 0.71 CHRM1 (0.60) CHRM1AKR1A1CHRM3HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060223888-A1 Valproic acid analogues and pharmaceutical composition thereof THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2006-10-05 US claimed
WO-2004054957-A2 VALPROIC ACID ANALOGUES AND PHARMACEUTICAL COMPOSITIONS THEREOF THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2004-07-01 WO claimed
US-20060223888-A1 Valproic acid analogues and pharmaceutical composition thereof THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2006-10-05 US disclosed
WO-2004054957-A2 VALPROIC ACID ANALOGUES AND PHARMACEUTICAL COMPOSITIONS THEREOF THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2004-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223888-A1 Valproic acid analogues and pharmaceutical composition thereof MALT1, HDAC11, GABRA6 CHRM1 2457/4885AKR1A1 1732/4885CHRM3 2287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.